‍Alluvi Healthcare Retatrutide Pens

8-16 Week supply
‍
A combined BPC-157 and TB-500 formulation (20mg each), supplied in a 40mg pre-filled research device. Alluvi Healthcare Retatrutide Pens

Produced exclusively for controlled laboratory R&D applications. Provided in sealed batches to support compound stability analysis, delivery mechanism evaluation, and formulation studies.

‍Each BPC-157 & TB-500 40mg Pen Kit Includes:
‍Pre-filled Research pen (40mg total: 20mg BPC-157 + 20mg TB-500)
Research information sheet

‍Storage:
– Store refrigerated (2–8°C). Do not freeze.
– Supplied in fixed-volume sealed format for laboratory analysis.‍
‍
Delivery: Dispatched with a cold pack
‍Tracked 2 DAY UK Delivery And 1-5 Days Worldwide

Research & Development purposes.

Alluvi Healthcare Retatrutide Pens